相关实验视频
Updated: Jan 10, 2026

06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
24.1K
库辛综合征中的高凝血:过去,现在,未来.
Amit Akirov1,2, Maria Fleseriu3
1Institute of Endocrinology, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel.
Archives of endocrinology and metabolism
|November 28, 2025
概括
患有库辛综合征的患者面临高静脉血栓栓塞的风险,由于高皮质醇. 建议进行预防,但需要标准化的方案,以更好地预防深静脉血栓塞和肺栓塞.
科学领域:
- 内分泌学 在内分泌学.
- 血液学 血液学 血液学
- 血管医学 血管医学
背景情况:
- 库辛综合征涉及长期的葡萄糖皮质激素过量,导致多系统并发症.
- 在库辛综合征患者中,静脉血栓栓塞 (VTE) 风险增加,包括DVT和PE,已得到充分证实.
- 过高皮质醇症通过内皮质功能障碍,增加的血凝因子,纤维素分解受损和静脉静止引起高凝血状态.
研究的目的:
- 审查将库辛综合征与VTE联系在一起的机制.
- 讨论目前在库辛综合征中进行血栓预防的建议.
- 识别知识上的差距,并建议未来的研究方向.
主要方法:
- 对库辛综合征中VTE的流行病学研究的综述.
- 分析有助于高凝固能力的机制.
- 综合目前关于血栓预防的共识建议.
主要成果:
- 库辛综合征显著增加了静脉瘤风险,即使在生化缓解后也会持续存在.
- 肥胖,高血压和糖尿病等常见的并发症加剧了血栓形成的风险.
- 协商一致的指导方针建议大多数患者进行血栓预防,使用LMWH作为首选的抗凝剂.
结论:
- 由于临床实践的变化,标准化的血栓预防方案至关重要.
- 需要进一步研究风险分层,预防持续时间和缓解后的长期结果.
- 研究DOAC和个性化医疗方法可能会改善库辛综合征的静脉瘤预防.
相关概念视频
Adrenal Gland Disorders
2.8K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
2.8K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Venous Thrombosis I: Introduction
310
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
310
Disorders of Hemostasis
2.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.0K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
521
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
521
Cardiomyopathy III: Hypertrophic Cardiomyopathy
374
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
374

